Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3576
CALL
MKS Inc
MKSI
$21B
| $1.86M | ﹤0.01% |
19,700
+200
| +1% | +$19.9K |
|
3577
Gran Tierra Energy
GTE
$325M
| $1.86M | ﹤0.01% |
68,506
+11,024
| +19% | +$246K |
|
3578
CALL
Jazz Pharmaceuticals
JAZZ
$15.9B
| $1.86M | ﹤0.01% |
13,800
-10,700
| -44% | -$1.48M |
|
3579
Precigen
PGEN
$2.18B
| $1.86M | ﹤0.01% |
161,272
+29,109
| +22% | +$434K |
|
|
BGG
3580
DELISTED
Briggs & Stratton Corp.
BGG
| $1.86M | ﹤0.01% |
73,230
-2,556
| -3% | -$62.8K |
|
3581
CALL
TotalEnergies
TTE
$196B
| $1.86M | ﹤0.01% |
3,078,600
-3,537,488
| -53% | -$2.11M |
|
|
ISCA
3582
DELISTED
International Speedway Corp
ISCA
| $1.85M | ﹤0.01% |
46,555
-32,490
| -41% | -$1.29M |
|
3583
CALL
Protolabs
PRLB
$2.2B
| $1.85M | ﹤0.01% |
18,000
+7,500
| +71% | +$673K |
|
3584
Timken Company
TKR
$9.25B
| $1.85M | ﹤0.01% |
37,696
-1,655,034
| -98% | -$80.1M |
|
3585
PUT
Flex
FLEX
$46.6B
| $1.85M | ﹤0.01% |
136,548
-1,327
| -1% | -$17.9K |
|
3586
iShares US Healthcare ETF
IYH
$3.75B
| $1.85M | ﹤0.01% |
53,125
-126,730
| -70% | -$4.4M |
|
3587
CALL
Plains GP Holdings
PAGP
$5.11B
| $1.85M | ﹤0.01% |
84,300
+1,300
| +2% | +$27.4K |
|
|
SNCR
3588
DELISTED
Synchronoss Technologies
SNCR
| $1.85M | ﹤0.01% |
22,984
-15,905
| -41% | -$1.54M |
|
3589
Visteon
VC
$2.89B
| $1.85M | ﹤0.01% |
14,774
-83,759
| -85% | -$10.6M |
|
3590
SouthState Bank Corp
SSB
$10.8B
| $1.85M | ﹤0.01% |
21,196
-35,281
| -62% | -$3.17M |
|
3591
PUT
RenaissanceRe
RNR
$13.4B
| $1.85M | ﹤0.01% |
14,700
+3,500
| +31% | +$470K |
|
|
CRC
3592
PUT
DELISTED
California Resources Corporation
CRC
| $1.84M | ﹤0.01% |
94,800
+4,700
| +5% | +$66K |
|
|
NGHC
3593
DELISTED
National General Holdings Corp
NGHC
| $1.84M | ﹤0.01% |
93,780
-68,554
| -42% | -$1.4M |
|
3594
CALL
Ionis Pharmaceuticals
IONS
$9.51B
| $1.84M | ﹤0.01% |
36,600
-37,800
| -51% | -$2.07M |
|
3595
Myriad Genetics
MYGN
$290M
| $1.84M | ﹤0.01% |
53,614
+38,902
| +264% | +$1.31M |
|
|
GOOS
3596
CALL
Canada Goose Holdings
GOOS
$854M
| $1.84M | ﹤0.01% |
58,300
+26,200
| +82% | +$643K |
|
|
3597
PUT
Visteon
VC
$2.89B
| $1.84M | ﹤0.01% |
14,700
+6,000
| +69% | +$760K |
|
3598
CALL
Axos Financial
AX
$5.8B
| $1.84M | ﹤0.01% |
61,500
-33,100
| -35% | -$900K |
|
3599
CALL
iShares US Financials ETF
IYF
$4.43B
| $1.84M | ﹤0.01% |
30,800
+17,600
| +133% | +$1.02M |
|
|
DOOR
3600
CALL
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $1.84M | ﹤0.01% |
24,800
+20,600
| +490% | +$1.44M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.